Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, August 9, 2022.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Strong Uptrend (+100) - NBIX is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, NBIX continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid NBIX?
MarketClub looks at technical strength and momentum to determine if the timing is right for NBIX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for NBIX
The long-term trend has been UP since Aug 5th, 2022 at 100.00
The intermediate-term trend has been UP since Aug 5th, 2022 at 99.41
The short-term trend has been UP since Aug 3rd, 2022 at 94.56
Smart Scan Analysis for NBIX
Based on our trend formula, NBIX is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 104.5000 | 109.2600 | 103.0872 | 106.9500 | +2.3600 |
| Prev. Close | Volume | Bid | Ask | Time |
| 104.5900 | 839423 | 2022-08-09 12:39:18 |
| Year High | 126.98 | Year High Date | 2018-09-13 |
| Year Low | 74.12 | Year Low Date | 2018-01-17 |
| 52wk High | 108.015 | 52wk High Date | 2021-11-01 |
| 52wk Low | 71.875 | 52wk Low Date | 2022-01-10 |
| Year End Close | 7.48 | Average Volume | 672,236 |
| Shares Outstanding | 95,639 | Short Interest | 2,757,358 |
| % Institutional | 82.1 | Market Cap | 8,737M |
| Assets | 214,450,000M | Liabilities | 753,400,000M |
| P/E Ratio | 143.274 | Beta | 0.3 |
| Volatility | 65.12 |